feed,title,long_url,short_url
Benzinga,Alnylam's Lumasiran Scores Expanded FDA Approval For Ultra Rare Genetic Disease,https://benzinga.com/general/biotech/22/10/29184060/alnylams-lumasiran-scores-expanded-fda-approval-for-ultra-rare-genetic-disease,https://bit.ly/3CGa2A1
Benzinga,This Favorable Sign Appears On TJX Companies's Chart,https://benzinga.com/markets/22/10/29185835/this-favorable-sign-appears-on-tjx-companiess-chart,https://bit.ly/3CGa3nz
Benzinga,Will Investors Notice Exciting Sign On Regal Rexnord's Chart?,https://benzinga.com/markets/22/10/29185834/will-investors-notice-exciting-sign-on-regal-rexnords-chart,https://bit.ly/3ypI5tI
Benzinga,Will Chart Analysts Notice Bad Omen on NiSource's Chart,https://benzinga.com/markets/22/10/29185833/will-chart-analysts-notice-bad-omen-on-nisources-chart,https://bit.ly/3VbrzXV
Benzinga,Will Chart Analysts Notice Bad Omen on Duke Energy's Chart,https://benzinga.com/markets/22/10/29185831/will-chart-analysts-notice-bad-omen-on-duke-energys-chart,https://bit.ly/3Cjtpxp
Benzinga,Death Cross Looms Over Amcor Investors,https://benzinga.com/markets/22/10/29185829/death-cross-looms-over-amcor-investors,https://bit.ly/3CGa2jv
